Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Total Liabilities (2024 - 2026)

Carlsmed filings provide 2 years of Total Liabilities readings, the most recent being $31.3 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 19.15% to $31.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $31.3 million, a 19.15% increase, with the full-year FY2025 number at $31.3 million, up 19.15% from a year prior.
  • Total Liabilities hit $31.3 million in Q4 2025 for Carlsmed, up from $28.2 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $66.0 million in Q3 2024 to a low of $26.2 million in Q4 2024.